Sofwave has FDA clearances for skin laxity treatment across multiple areas, including the upper arms, neck, submental region, and brow
Who It Is For Adults over 40 who are proactively focused on healthspan and longevity Patients who want to address aging at the cellular level rather than just managing symptoms Individuals interested in measurable anti-aging results (paired with TrueAge epigenetic testing to track biological age) Patients who have optimized the basics (sleep, nutrition, exercise) and want to add the next level of cellular support Those experiencing multiple signs of accelerated aging fatigue, cognitive decline, slow recovery, metabolic dysfunction simultaneously What to Expect Weeks 1-4: Improved sleep quality and energy (from sermorelin and NAD+)
: GI distress occurs in 1 out of 3 patients (often temporary)
Coronary CT angiography (CCTA) confirmed the diagnosis and excluded obstructive coronary artery disease
Clinical data from the SURPASS trials confirms this, showing A1C reductions of up to 2.6% and weight loss milestones between 15% and 22%